FDA Investigator Nicholas P Diorio

Nicholas P Diorio has inspections in 2 countries as of 13 Nov 2023. Nicholas P Diorio has collaborated with a combinined 3356 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

13 Nov 2023

Investigator Role:

FDA Investigator

Redica ID:

100007625

Country:

United States of America, China

Co-Investigator(s):

Alan M Barker, Alan M Roberts, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Ana E Morales, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew J Barrowcliff, Ann Marie Montemurro, Ann Marie Schofield, Anthony R Ronga, Antoinette L Chancey, Arsen Karapetyan, Ashley L Reiber, Audrey Dela Cruz, Barry Cherney, PhD, Bradley J Maunder, Brentley S Collins, Brian D Nicholas, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Brittany R Laymon, Bruce H Mccullough, Bruce Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carrie Ann Plucinski, CDR Ileana Barreto Pettit, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charisse K Green, Charles L Zhou, Chase S Baldwin, Chery Grandinetti, Christina A Miller, Christina V Santos, Christopher D Leach, Clinton J Lott, Clotia Cabbey Mensah, Dariusz Galezowski, David Perkins, Debra I Love, Debra L Boyd Seale, Dell S Moller, Denarvis C Mendenhall, Denise M Digiulio, Dr. S Nar Ali, PhD, Dr. Zhou Chen (nmi), MD PhD, Eboni S Funderburk, Elizabeth L Philpy, Emilie E Kahn, Enrico Joset Mangahis, Enrico Mangahis, Eric M Mueller, PharmD, Eric S Pittman, George Pyramides, Gregory R Dill, Howard Sklamberg, Humera Khan, Jacob G Luts, Jacob G Lutz, James E Roberts, James P Duggan, James W Plucinski, Janae D Price, Jason F Chancey, Jayne E Holcomb, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Johnson, Jeremy W Rotton, Jesse A Vazquez, Jill J Tillman, Jocelyn C Turner, Joel D Hustedt, John M Seale, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Justin R Hays, Karen Emasley Joseph, Kathleen S Tormey, Kristen E Szenderski, Kshitij A Patkar, Kujtim Sadiku, Latoya A Griffith, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Laurimer Kuilan Torres, LCDR Michael H Tollon, Leeterry Moore, Lequita M Mayhew, Leslie D Hintz, Liliya V Bubiy, Lisa Hayka, Lisa Hornback, Lisa M Bellows, Lisa M Feola, Logan M Ebeling, Lorelei S Jarrell, Maksim A Levenchuk, Marcia A Worley, Margaret Torres Vazquez, Marie Bbuen Bigornia, Mark G Peterson, Mark I Kaspar, Michael A Taylor, Michael D Robinson, Michael E Maselli, Michele L Glendenning, Michele Perry Williams, Micmarie Ramos, Mihaly S Ligmond, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas Z Lu, Nicole E Knowlton, Nicole J Clausen, Nicole S Williams, Norman K Starks, Norman L Brown, Pablo Alcantara, Paola S Barnett, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paul L Bellamy, Paula A Trost, Paula P Demichael, Peng Zhou, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Rachel T Evans, Rafael Padilla, Ralph A Erickson, Rebecca K Olin, Rebecca Rodriguez, Regan T Harp, Regina T Brown, Rita K Kabaso, Robert J Ham, Rona Leblanc, PhD, Rosemary A Sexton, Roshni J Patel, Ross J Grigsby, Russ R Rivy, Russell K Riley, Ruth Smith, Samina S Khan, Sandra A Hughes, Sean P Ryan, Shafiq S Ahadi, Shalonda C Clifford, Shana L Williams, Simone E Pitts, State Agency, Stefen D Mcmillan, Stephen C Mahoney, Stephen D Eich, Sullan, Susan D Yuscius, Susan P Bruederle, Susan Yuscius, Syed N Ali, Tamara Brey, Tara C Alcazar, Tenzin Jangchup, That Q Dang, Thomas J Arista, Todd M Stankewicz, Torrey M Ward, Vaishali J Patel, Veronica Fuentes, MS, Vioela J Caze, William D Sherman, William R Weissinger, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Yvonne E Lozano, Yvonne Lozano

Nicholas P Diorio's Documents

Publish Date	Document Type	Title
March, 2013	FDA 483	The Compounding Shop, Inc. - Form 483, 2013-03-25
September, 2019	FDA 483	Novum Pharma, LLC - Form 483, 2019-09-24
May, 2013	FDA 483	Rising Pharma Holdings, Inc. - Form 483, 2013-05-03
February, 2010	FDA 483	Microbiological Testing & Consulting, LLC - Form 483, 2010-02-24
September, 2016	FDA 483 Response	Sage Products LLC - Form 483R, 2016-09-22
May, 2011	FDA 483	Blistex Inc. - Form 483, 2011-05-10
August, 2015	EIR	AbbVie Inc. - EIR, 2015-08-06
June, 2017	EIR	Horizon Pharma Inc - US Operations - EIR, 2017-06-06
September, 2011	EIR	Medefil, Inc. - EIR, 2011-09-06
January, 2022	FDA 483	American Chinese Medicine Association, Inc - Form 483, 2022-01-20
May, 2013	FDA 483 Response	Rising Pharma Holdings, Inc. - Form 483R, 2013-05-03
October, 2009	FDA 483	Sage Products LLC - Form 483, 2009-10-01
December, 2009	FDA 483	Thornton Industries, Inc. - Form 483, 2009-12-18
December, 2015	FDA 483	Isomedix Operations Inc - Form 483, 2015-12-03
March, 2018	FDA 483	Xttrium Laboratories, Inc. - Form 483, 2018-03-15
January, 2023	FDA 483	SGS North America Inc. - Form 483, 2023-01-10
May, 2009	FDA 483	Pharmaceutical Laboratories and Consultants, Inc. - Form 483, 2009-05-21
September, 2010	FDA 483	Blue Island Phenol LLC - Form 483, 2010-09-29
September, 2017	FDA 483	Primrose Candy Company - Form 483, 2017-09-26
September, 2016	FDA 483	Sage Products LLC - Form 483, 2016-09-01
April, 2011	FDA 483	Deibel Laboratories of Illinois, Inc. - Form 483, 2011-04-21
August, 2015	FDA 483	AbbVie Inc. - Form 483, 2015-08-06
December, 2014	FDA 483	J.M. Huber Micropowders, Inc. - Form 483, 2014-12-17
April, 2014	EIR	Medline Industries, Inc. - EIR, 2014-04-02
March, 2019	EIR	DENTAL TECHNOLOGIES, INC. - EIR, 2019-03-12
March, 2016	EIR	Shandong Xinhua Pharmaceutical Company Limited Hutian Branch - EIR, 2016-03-31
December, 2012	EIR	Medefil, Inc. - EIR, 2012-12-20
June, 2022	FDA 483	Fresenius Kabi USA, LLC - Form 483, 2022-06-30
August, 2015	FDA 483 Response	AbbVie Inc. - Form 483R, 2015-08-06
December, 2010	FDA 483	Rose Laboratories, Inc. - Form 483, 2010-12-01
August, 2014	FDA 483	Vantage Oleochemicals, Inc. - Form 483, 2014-08-21
September, 2016	EIR	Sage Products LLC - EIR, 2016-09-01
December, 2012	FDA 483	Medefil, Inc. - Form 483, 2012-12-20
September, 2011	FDA 483	Medefil, Inc. - Form 483, 2011-09-06
September, 2014	EIR	Horizon Pharma USA, Inc. - EIR, 2014-09-30
June, 2012	FDA 483	Deibel Laboratories of Illinois, Inc. - Form 483, 2012-06-13
March, 2019	FDA 483	DENTAL TECHNOLOGIES, INC. - Form 483, 2019-03-12
May, 2018	EIR	Avatar Corporation - EIR, 2023-10-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more